pharmaphorum
MAY 7, 2021
George Underwood is the editor for pharmaphorum’s Deep Dive digital magazine. He has been reporting on the pharma industry since 2014 and has worked at a number of leading publications in the UK. About the author. The post Why relationships are key in rare disease patient engagement appeared first on.
Pulses
MAY 4, 2023
Magazine S, Handwerk B. Smithsonian Magazine. Make It Stick: The Science of Successful Learning. Cambridge, MA. The Belknap Press of Harvard University Press. The Art of Memory. London: Pimlico, 1966. Neuroscientists Unlock the Secrets of Memory Champions. link] Qureshi A, Rizvi F, Syed A, Shahid A, Manzoor H.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
JUNE 21, 2022
The move to ICSs has been ongoing since 2014 and the change that the formal adoption of ICSs brings is fundamental. Fundamental change in mindset. The post ICSs: improving patient and market access at a local level appeared first on.
pharmaphorum
APRIL 26, 2021
George Underwood is the editor for pharmaphorum’s Deep Dive digital magazine. He has been reporting on the pharma industry since 2014 and has worked at a number of leading publications in the UK. In 2019, she was included in the MIT Technology Review’s Innovators Under 35 list. About the author. He can be contacted on LinkedIn.
pharmaphorum
MAY 25, 2021
George Underwood is the editor for pharmaphorum’s Deep Dive digital magazine. He has been reporting on the pharma industry since 2014 and has worked at a number of leading publications in the UK. About the author. The post New Cell & Gene Therapy Collective seeks to boost UK adoption appeared first on.
pharmaphorum
JUNE 8, 2021
George Underwood is the editor for pharmaphorum’s Deep Dive digital magazine. He has been reporting on the pharma industry since 2014 and has worked at a number of leading publications in the UK. He has been a member of the American Society of Hematology since 2006 and was involved in the management of Antengene since April 2017.
pharmaphorum
FEBRUARY 18, 2021
Eli Lilly’s Humalog compound and formulation patents expired in 2013 and 2014, respectively. They employed hundreds of new salespeople to detail doctors and hospitals, spent millions on TV and magazine ads and handed out masses of free samples. In late 2017, the FDA approved Admelog, Sanofi’s biosimilar of Humalog.
Expert insights. Personalized for you.
126 
Let's personalize your content